(Q39476565)

12 September 2017

Acacetin causes a frequency- and use-dependent blockade of hKv1.5 channels by binding to the S6 domain (English)

1 reference

Paul Michel Georges Remi Vanhoutte

12 September 2017

11

object named as

Paul M Vanhoutte

1 reference

12 September 2017

Hui-Jun Wu

1

1 reference

12 September 2017

Wei Wu

2

1 reference

12 September 2017

Hai-Ying Sun

3

1 reference

12 September 2017

Guo-Wei Qin

4

1 reference

12 September 2017

Hong-Bing Wang

5

1 reference

12 September 2017

Panwen Wang

6

1 reference

12 September 2017

Hari Krishna Yalamanchili

7

1 reference

12 September 2017

Junwen Wang

8

1 reference

12 September 2017

Hung-Fat Tse

9

1 reference

12 September 2017

Chu-Pak Lau

10

1 reference

12 September 2017

Gui-Rong Li

12

1 reference

12 September 2017

27 August 2011

1 reference

Journal of Molecular and Cellular Cardiology

12 September 2017

1 reference

12 September 2017

51

1 reference

12 September 2017

966-973

1 reference

12 September 2017

6

1 reference

Epidemiology and natural history of atrial fibrillation: clinical implications

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Antiarrhythmic drugs in atrial fibrillation: an overview of new agents, their mechanisms of action and potential clinical utility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

"Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

IKur/Kv1.5 channel blockers for the treatment of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Identity of a novel delayed rectifier current from human heart with a cloned K+ channel current.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Evidence for two components of delayed rectifier K+ current in human ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Antisense oligodeoxynucleotides directed against Kv1.5 mRNA specifically inhibit ultrarapid delayed rectifier K+ current in cultured adult human atrial myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Delayed rectifier outward current and repolarization in human atrial myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

The 5-HT2 antagonist ketanserin is an open channel blocker of human cardiac ether-à-go-go-related gene (hERG) potassium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

The membrane permeable calcium chelator BAPTA-AM directly blocks human ether a-go-go-related gene potassium channels stably expressed in HEK 293 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Human Kir2.1 channel carries a transient outward potassium current with inward rectification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Structure of the full-length Shaker potassium channel Kv1.2 by normal-mode-based X-ray crystallographic refinement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Structural determinants of Kvbeta1.3-induced channel inactivation: a hairpin modulated by PIP2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Binding site of a novel Kv1.5 blocker: a "foot in the door" against atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Molecular basis for a high-potency open-channel block of Kv1.5 channel by the endocannabinoid anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Inhibition of ultra-rapid delayed rectifier K+ current by verapamil in human atrial myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

New drugs targeting the cardiac ultra-rapid delayed-rectifier current (I Kur): rationale, pharmacology and evidence for potential therapeutic value

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Omega-3 polyunsaturated fatty acids inhibit transient outward and ultra-rapid delayed rectifier K+currents and Na+current in human atrial myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Class III antiarrhythmic effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Pharmacology of cardiac potassium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Molecular basis for Kv1.5 channel block: conservation of drug binding sites among voltage-gated K+ channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Molecular determinants of stereoselective bupivacaine block of hKv1.5 channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Putative binding sites for benzocaine on a human cardiac cloned channel (Kv1.5).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Molecular determinants of Kv1.5 channel block by diphenyl phosphine oxide-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

The molecular basis of high-affinity binding of the antiarrhythmic compound vernakalant (RSD1235) to Kv1.5 channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Blocker protection in the pore of a voltage-gated K+ channel and its structural implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Binding of correolide to the K(v)1.3 potassium channel: characterization of the binding domain by site-directed mutagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

Quercetin activates human Kv1.5 channels by a residue I502 in the S6 segment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.022

10.1016/J.YJMCC.2011.08.022

7 January 2021

Identifiers

DOI

1 reference

release_gjj46f3bfrafvo22euhkosfxxe

12 September 2017

0 references

1 reference